Rate My Professor Mark Wilkinson

His clinical practice focuses on eye care, inherited eye diseases, low vision management, vision rehabilitation, optometry services, and vision training therapy. Wilkinson participates in open clinical trials, notably as a member of the gene replacement clinical trial team for the RPE65 form of Leber's Congenital Amaurosis. Research interests encompass driving performance under visual acuity, visual field, or cognitive impairments; phenotypic variations in inherited eye diseases; and interventions for children with visual impairments, including literacy challenges. Key publications include 'Low Vision Rehabilitation: An Update' (2017), 'Auditory Global Positioning System and Advanced Driver Assistance Systems: A Safer Alternative to Bioptic Telescopes for Drivers Who Are Visually Impaired?' (2018), 'Predominance of hyperopia in autosomal dominant Best vitelliform macular dystrophy' (2020), 'A Retrospective Longitudinal Study of 460 Patients with ABCA4-Associated Retinal Disease' (2024), and 'Functional Assessment of FECD in the National Advanced Driving Simulator: Initial Study of Nighttime Glare and Scheimpflug Imaging' (2025). With over 500 citations across 34 publications, his contributions advance vision rehabilitation and safe mobility for visually impaired individuals. He has served on the low vision subcommittee of the National Eye Health Education Program, enhancing public awareness and clinical practices in the field.